New biomarkers for LTBI in IGRAs supernatants

M. Shibasaki, M. Matsushima, Y. Kitagawa, T. Kawabe (Oobu, Nagoya, Japan)

Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Session: Clinical challenges in tuberculosis
Session type: Thematic Poster Session
Number: 2724
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Shibasaki, M. Matsushima, Y. Kitagawa, T. Kawabe (Oobu, Nagoya, Japan). New biomarkers for LTBI in IGRAs supernatants. Eur Respir J 2011; 38: Suppl. 55, 2724

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of IP-10 in IGRA for LTBI diagnosis
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018



Differentiating smear-negative active tuberculosis from LTBI by BAL ELISPOT: a TBNET study
Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis
Year: 2009



Clinical evaluation of diagnostic potential of several biomarkers for immunodiagnosis of tuberculosis infection including IGRAs
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015

Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

Clinical management of LTBI (PDF)// IGRAs for the diagnosis of tuberculosis (PPT)
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012


Predictive value of a whole-blood IGRA for the development of active TB disease
Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Year: 2008


Interferon-gamma release assays (IGRA) for latent tuberculosis infection (LTBI) in children
Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood
Year: 2011


Concordance between tuberculin skin testing and interferon-gamma release assays in diagnosis of latent tuberculosis infection among HIV-infected individuals
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012

Clinical evaluation of interferon-gamma release assay (IGRA) in patients with nontuberculous mycobacterial disease
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012

IGRAs and other TB infection tests
Source: ERS webinar 2021: IGRAs and other TB infection tests
Year: 2021


Comparison of BAL ELISPOT and NAT for the diagnosis of smear-negative tuberculosis – a TBNET study
Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease
Year: 2008


Negative effect of ferritin levels on T-SPOT.TB, an enzyme-linked immunospot based interferon-gamma release assay using Mycobacterium tuberculosis specific antigens, in the smear-positive active pulmonary tuberculosis.
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018


Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms
Source: Eur Respir J 2011; 39: 163-171
Year: 2012



Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms
Source: Eur Respir J 2012; 39: 163-171
Year: 2012



Performance of two interferon-gamma release assays (T-SPOT.TB and QuantiFERON-TB GOLD In Tube) increase diagnostic yield of tuberculin skin testing for detection of latent tuberculosis in patients with inflammatory bowel disease
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011


Discordance between tuberculin skin tests (TST) and interferon gamma release assays (IGRAs): Are we over-treating LTBI?
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018




Modulation of whole-blood IGRA response in patients with latent TB infection during treatment
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018



Clinical evaluation of IP-10 and MIG including IGRAs (QFT and T-SPOT) for the diagnosis of tuberculosis infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

Comparison of whole-blood interferon-gamma release assay and tuberculin skin test results for the prediction of active tuberculosis disease in HIV-infected individuals
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009


Comparative study of the usefulness of TST and three interferon-gamma release assasys (IGRAs) for the differential diagnosis of pulmonary tuberculosis
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011